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Background: Cell-based therapies show promise in repairing cardiac tissue and improving contractile performance
following a myocardial infarction. Despite this, ischemia-induced death of transplanted cells remains a major hurdle
to the efficacy of treatment. ‘Superhealer’ MRL/MpJ mesenchymal stem cells (MRL-MSCs) have been reported to
exhibit increased engraftment resulting in reduced infarct size and enhanced contractile function. This study
determines whether intrinsic differences in mitochondrial oxidative phosphorylation (OXPHOS) assist in explaining
the enhanced cellular survival and engraftment of MRL-MSCs.
Findings: Compared to wild type MSCs (WT-MSCs), mitochondria from intact MRL-MSCs exhibited an increase in
routine respiration and maximal electron transport capacity by 2.0- and 3.5-fold, respectively. When routine oxygen
utilization is expressed as a portion of maximal cellular oxygen flux, the MRL-MSCs have a greater spare respiratory
capcity. Additionally, glutamate/malate- and succinate-supported oxygen consumption in permeabilized cells was
elevated approximately 1.25- and 1.4-fold in the MRL-MSCs, respectively.
Conclusion: The results from intact and permeabilized MSCs indicate MRL-MSCs exhibit a greater reliance on and
capacity for aerobic metabolism. The greater capacity for oxidative metabolism may provide a protective effect by
increasing ATP synthesis per unit substrate and prevent glycolysis-mediated acidosis and subsequent cell death
upon transplantation into the glucose-and oxygen-deprived environment of the infarcted heart.
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Background
Advances in stem cell therapy for treating a myocardial
infarction (MI) are impeded by inadequate survival and
engraftment of implanted cells in the host tissue. Up to
99% of mesenchymal stem cells (MSCs) experience cell
death following administration into the infarcted heart
[1,2]. A predominant factor for the poor survival is
ischemia [3,4]. Ischemia results in ATP depletion, a
reduction in mitochondrial oxidative phosphorylation
(OXPHOS) and increased reliance on glycolysis leading
to cellular acidosis and cell death [4].* Correspondence: cchughey@ucalgary.ca
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reproduction in any medium, provided the orThe bone marrow-derived ‘Superhealer’ MRL/MpJ
MSC (MRL-MSC) has been reported to exhibit greater
engraftment in the infarcted heart [5]. This improved re-
tention promotes superior cardio-protection as indicated
by increased angiogenesis, reduced infarct size and
improved contractility in a murine MI model [5]. The
primary contributor of MRL-MSC-mediated wound re-
pair and cardiac contractile improvements was identified
as the paracrine/autocrine factor, secreted frizzled
related receptor protein 2 (sFRP2) [5,6]. sFRP2 is a
member of the sFRP family that exhibits a cysteine-rich
domain that binds Wnt glycoproteins [7]. sFRP binding
diminishes Wnt interactions with frizzled receptors,
which propagate apoptosis through the canonical β-
catenin pathway [8]. In addition to its involvement in
apoptosis, Wnt/β-catenin signaling promotes a switch in
glucose metabolism from OXPHOS to glycolysis [9].
Given the infarcted region of the heart receives
impaired oxygen and nutrient supply, the current studyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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differences in the MRL-MSC oxygen utilization and
mitochondrial energetics could explain their enhanced
viability.
Methods
MSCs and cardiac myocytes
Procedures were approved by the University of Calgary
and Vanderbilt University Animal Care and Use Com-
mittees. Murine WT- and MRL-MSCs were generated
and expanded from C57BL6 and MRL/MpJ strains, re-
spectively, as described [5,10]. Briefly, WT- and MRL-
MSCs were cultured in a humidified atmosphere
containing 5% CO2 at 37°C in low glucose Dulbecco’s
Modified Eagle Medium (DMEM; GIBCO) containing
1000 mg/L glucose, 110 mg/L sodium pyruvate, 10%
defined fetal bovine serum (FBS; HyClone), 10%
penicillin-streptomycin, 10% fungizone and 10 μg/L
platelet-derived growth factor-ββ (PDGF-ββ; R&D Sys-
tems). The immunophenotype of MSCs were CD44+,
LY6A/E/Sca1+, CD45−, CD14−, CD11b−, CD16/32−,
CD144− and CD146− as previously reported [5]. MSC
capacity for trilineage differentiation was confirmed as
previously described [5]. Passage 4 through 14 were used
for all measurements. Primary cardiac myocytes from
10wk old, male, CD-1 mice were isolated using a col-
lagenase digestion method as previously described [11].
High-resolution respirometry
Cellular respiration was measured using the Oxygraph-
2k (Oroboros Instruments) at 37°C. Experiments evalu-
ating intact cell respiration were performed with MSCs
suspended in culture medium consisting of low glucose
Dulbecco’s Modified Eagle Medium (DMEM; GIBCO)
containing 1000 mg/L glucose and 110 mg/L sodium
pyruvate. Experiments evaluating permeabilized cell oxy-
gen consumption were performed with MSCs suspended
in a mitochondrial respiration medium (MiR05) contain-
ing 0.5 mM EGTA, 3 mM MgCl2.6H2O, 20 mM taurine,
10 mM KH2P04, 20 mM HEPES, 1 g/L BSA, 60 mM
potassium-lactobionate, 110 mM sucrose, pH 7.1 [12].
A phosphorylation control protocol was performed to
assess intact cell respiration [13]. Without substrate
addition, routine respiration (RDMEM) was determined.
Oligomycin (2 μg/ml) evaluated futile oxygen flux (LEAK)
[14]. Maximal capacity of the electron transfer system
(ETS) was evaluated via the step-wise (0.5 μM steps) titra-
tion of carbonyl cyanide-p-trifluoromethoxyphenylhydraz
-one (FCCP). All respiratory states were corrected for re-
sidual/non-mitochondrial oxygen consumption (0.5 μM
rotenone and 2.5 μM antimycin A).
Digitonin-permeabilized cell analysis was employed to
assess complexes I and II. Optimal digitonin concentra-
tions required to permeabilize MSCs were determinedas previously outlined [15]. Cardiac myocytes were per-
meabilized with digitonin as indicated by Liu et al.
(1991) [16]. Routine respiration (RMiR05) was identified
in MiR05. State 2 respiration (VCI) was assessed by the
addition of complex I substrates glutamate (10 mM) and
malate (2 mM). ADP (5 mM) induced state 3 respi-
ration/maximal oxygen consumption (VMAX-CI). A sub-
sequent titration of succinate (10 mM) allowed for
evaluation of state 3 respiration by convergent electron
input. Convergent electron input is defined as electrons
being passed through a series of oxido-reduction reac-
tions from both complex I and II to the Q-junction
which is followed by the flow of electrons through com-
plex III, cytochrome c and complex IV [17]. Inhibition
of complex I with 0.5 μM rotenone revealed succinate-
supported respiration (VMAX-CII). The acceptor control
ratio (ACR) was defined as VMAX-CI relative to VCI. A ti-
tration of 10 μm cytochrome c evaluated intactness of
the outer mitochondrial membrane and provided quality
control for the digitonin-permabilized cell preparations.
Nutrient deprivation and ischemic culture conditions
WT-and MRL-MSCs were plated at a density of 3000
cells/cm2 on 58 cm2 dishes (Nunc) for two days under the
previously described conditions. The cells were washed
with Dulbecco’s phosphate buffered saline (GIBCO) and
randomly segregated into three groups: control, glucose-
deprived and ischemic. Control cells were cultured in a
humidified atmosphere of 5% CO2 and 37°C in low glu-
cose DMEM (GIBCO) containing 1000 mg/L glucose,
110 mg/L sodium pyruvate, 10% defined fetal bovine
serum (FBS; HyClone), 10% penicillin-streptomycin, 10%
fungizone and 10 μg/ml platelet-derived growth factor-ββ
(PDGF-ββ; R&D Systems). Glucose-deprived cells were
cultured at 5% CO2 and 37°C in no glucose DMEM
(GIBCO) supplemented with 10 mg/L glucose, 1.1 mg/L
sodium pyruvate, 10% penicillin-streptomycin, 10% fungi-
zone creating conditions of 1% glucose and pyruvate com-
pared to the control group. Ischemic conditions were
identical to the glucose-deprived MSCs with the addition
of 12 ml of sterile mineral oil (Sigma) creating an oil layer
of approximately 5 mm over the cells to induce an
oxygen-deprived environment. The WT-and MRL-MSCs
remained under these conditions for 48 hr prior to further
analysis. The length of culture conditions was chosen to
provide the most relevance to cell-based therapy for the
infarcted heart. Intramyocardial injection of stem cells
into the acutely infarcted heart has been reported to result
in approximately 40-50% retention (of total transplanted
cells) 1–2 hours following transplantation [4,18,19]. The
initial attrition of cells within two hours of delivery via dir-
ect intramyocardial injection is largely the consequence of
cell leak from the injection site, being “washed away” by
local bleeding resulting from the injection and/or being
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remaining in the cardiac tissue, further cell death/loss
occurs in the first 48 hr (1-25% of total transplanted cells
are retained) with cell death stabilizing by seven days fol-
lowing delivery [4,18,19].Flow cytometry
Flow cytometry (Guava easyCyte 6HT 2 L; Millipore) was
employed to measure the level of apoptosis induced by
simulated glucose deprivation and ischemia. FlowCellect
MitoLive Kit (Millipore) was performed according to the
manufacturer's instructions to detect three cellular states:
Healthy, viable cells (intact mitochondrial membrane po-
tential and intracellular esterase activity), early apoptosis
(impaired mitochondrial membrane potential) and late
apoptotic/cell death events (impaired mitochondrial mem-
brane potential and intracellular esterase activity). Mito-
sense red with an excitation/emission wavelength of 640/
650 nm is employed by the FlowCellet MitoLive Kit (Milli-
pore) to evaluate mitochondrial membrane potential. Cal-
cein, acetoxymethlester (AM) is cell permeant non-and
non-flurorescent. This compound is hydrolyzed by intra-










































Figure 1 Oxygen flux in intact wild-type mesenchymal stem cells (WT
RDMEM, LEAK and ETS oxygen consumption in intact WT-MSC and MRL-MSC
consumption independent of ADP phosphorylation and ETS indicates max
oxygen flux in differing respiratory control states, normalized to a defined r
WT-MSC.excitation/emission wavelength of 488/525 nm which is
utilized by the FlowCellet MitoLive Kit (Millipore) to as-
sess cellular vitality.Statistical analyses
Two-way repeated measures ANOVAs were utilized to
assess statistical differences in high-resolution respiro-
metry experiments (p< 0.05). One-way ANOVAs were
performed for all other experimental measures. Differ-
ences within the ANOVAs were determined using
Tukey’s post hoc. Data are reported as means ± SEM.Results
The initial incubation in culture medium allowed for
determination of RDMEM. RDMEM in WT-MSCs was
33.1 ± 2.5 pmol O2/s/10
6 cells (Figure 1A). MRL-MSC
RDMEM was elevated at 69.4 ± 3.9 pmol O2/s/10
6 cells
(Figure 1A). Oligomycin-induced LEAK respiration
allowed for determination of non-ADP phosphorylating
oxygen utilization. LEAK respiration was similar be-
tween WT-MSCs compared to the MRL-MSCs,
11.7 ± 1.2 vs. 20.0 ± 1.6 pmol O2/s/10
6 cells (Figure 1A).





-MSC) and MRL/MpJ mesenchymal stem cells (MRL-MSC). (A)
. RDMEM represents routine respiration, LEAK represents oxygen
imal electron transport capacity. (B) Flux control ratios (FCR). Ratios of
eference respiratory state. n = 6, data are mean ± S.E.M. *p< 0.05 vs.
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of 54.4 ± 7.4 pmol O2/s/10
6 cells was lower than the
MRL-MSCs ETS of 190.1 ± 15.3 pmol O2/s/10
6 cells
(Figure 1A). These results indicate that absolute oxygen
flux in the routine repiratory state and maximal respira-
tory rate are elevated in the MRL-MSCs.
LEAK respiration operates at 0.25 ± 0.05 of ETS in the
WT-MSCs compared to 0.11 ± 0.01 of ETS in MRL-
MSCs (Figure 1B). This indicates a higher portion of
maximal electron transport system capacity is used for
futile reactions in WT-MSCs. The LEAK/RDMEM ratio
was not altered between cell types. LEAK oxygen flux
was 0.36 ± 0.04 of WT-MSC RDMEM compared to
0.31 ± 0.02 of MRL-MSC RDMEM (Figure 1B). RDMEM
functions at 0.65 ± 0.06 of ETS in WT-MSCs which was
significantly higher than the RDMEM/ETS ratio of
0.35 ± 0.01 exhibited by MRL-MSCs (Figure 1B). The
lower RDMEM/ETS ratio in the MRL-MSCs indicates that
the ‘Superhealer’ cell type display a greater potential





















































Figure 2 Oxygen flux in permeabilized wild-type mesenchymal stem
(A) Routine respiration in MiR05 (RMiR05) in intact MSCs. State 2 oxygen con
in digitoin-permabilized MSCs. State 3 or maximal oxygen consumption th
digitoin-permabilized MSCs. State 3 or maximal oxygen consumption throu
permabilized MSCs. (B) Given MSCs are transplanted into the infarcted hea
metabolic reference state. Cardiac myocyte state 2 oxygen consumption th
permabilized cardiac myocytes. State 3 or maximal oxygen consumption th
digitoin-permabilized cardiac myocytes. State 3 or maximal oxygen consum
permabilized cardiac myocytes. (C) Acceptor control ratio (ACR; defined as
†p< 0.05 vs. MRL-MSC.Oxygen consumption in permeabilized cells was evalu-
ated to obtain a greater understanding of the OXPHOS
function. Suspension of intact MSCs in MiR05 did not
change routine respiration. RMiR05 remained significantly
lower in the WT-MSCs, 37.3± 4.7 vs. 63.5± 3.3 pmol O2/
s/106 cells (Figure 2A). State 2 respiration (VCI), was simi-
lar between WT- and MRL-MSCs. WT-MSC state 2 res-
piration was 11.4± 0.6 pmol O2/s/10
6 cells compared to
the MRL-MSC respiration of 21.8± 2.7 pmol O2/s 10
6
cells (Figure 2A). Following the addition of ADP, state 3
(VMAX-CI) was lower in the WT-MSCs compared to the
MRL-MSCs, 90.0± 13.0 vs. 112.0 ± 2.7 pmol O2/s/10
6 cells
(Figure 2A). In addition, state 3 in WT-MSCs supported
by succinate alone (VMAX-CII) was 102.0 ± 2.8 pmol O2/s/
106 cells. This was significantly lower than the VMAX-CII
exhibited by MRL-MSCs, 140.1 ± 5.7 pmol O2/s/10
6 cells
(Figure 2A). As a comparison, isolated cardiac myocyte
oxygen flux was higher than that of both WT- and MRL-
MSCs. Isolated, cardiac myocyte VCI, VMAX-CI and
VMAX-CII were 1.44±0.24, 6.84±1.08 and 18.33±2.18 nmol
O2/s/10























cells (WT-MSC) and MRL/MpJ mesenchymal stem cells (MRL-MSC).
sumption through Complex I supported by glutamate and malate (VCI)
rough Complex I supported by glutamate and malate (VMAX-CI) in
gh Complex II supported by succinate (VMAX-CII) in digitoin-
rt, isolated, primary cardiac myocyte oxygen utilization is provided as a
rough Complex I supported by glutamate and malate (VCI) in digitoin-
rough Complex I supported by glutamate and malate (VMAX-CI) in
ption through Complex II supported by succinate (VMAX-CII) in digitoin-
VMAX-CI/VCI). n = 6-9, data are mean ± S.E.M. *p< 0.05 vs. WT-MSC.
BC
A
Figure 3 Effects of 48-hour glucose deprivation and ischemia on wild-type mesenchymal stem cell (WT-MSC) and MRL/MpJ
mesenchymal stem cell (MRL-MSC) apoptosis. (A) Representative fluorescence-activated cell sorting analysis of apoptotic cells after mitosense
red and calcein, AM staining. Healthy, viable MSCs are mitosense red+/calcein, AM+. The mitosense red-/calcein, AM+ MSCs are in the early
apoptotic phase, whereas the mitosense red-/calcein, AM+ MSCs are in the late apoptotic/cell death phase. (B) Quantitation of MSC early
apoptosis induced by 48 hr glucose deprivation and ischemia with mitosense red and calcein, AM staining. The graph shows the percentage of
all MSCs that are mitosense red-/calcein, AM+ MSCs after glucose deprivation and ischemia. (C) Quantitation of MSC late apoptosis/cell death
induced by 48 hr glucose deprivation and ischemia with mitosense red and calcein, AM staining. The graph shows the percentage of all MSCs
that are mitosense red-/calcein, AM- MSCs after glucose deprivation and ischemia. n = 6-7 independent experiments, data are mean ± S.E.M.
*p< 0.05 vs. WT-MSC Control. †p< 0.05 vs. MRL-MSC Control. }p< 0.05 vs. WT-MSC of identical experimental conditions. }p< 0.05 vs. WT-MSC
Glucose Deprivation. #p< 0.05 vs. MRL-MSC Glucose Deprivation.
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(Figure 2C).
Manipulation of culture conditions to simulate 48 hr
glucose deprivation exhibit a clear induction of early apop-
tosis defined by mitochondrial membrane potential im-
pairment (Figure 3A & B). WT-MSCs under glucose
deprivation-only conditions for 48 hr resulted in a drastic
increase in early apoptosis (43.61 ±7.59% vs. 2.57± 0.69%;
Figure 3B). The effect of glucose deprivation on MRL-
MSCs also resulted in an increased percentage of cells
undergoing early apoptosis (8.02± 1.37% vs. 1.16± 0.69%;
Figure 3B). However, the proportion of mitochondrial
membrane impaired MRL-MSCs was significantly lower
than that of WT-MSCs following glucose deprivation
(8.02 ± 1.37% vs. 43.61 ± 7.59%; Figure 3B). Interestingly, is-
chemic culture conditions did not promote significant
increases in early apoptotic WT-MSCs or MRL-MSCs
compared to control MSCs (Figure 3B). Furthermore, the
reduced oxygen availability may have provided a mito-
chondrial protective effect in the presence of glucose
deprivation as the WT-MSCs (43.61± 7.59% vs.
6.29± 2.55%; Figure 3B) and MRL-MSCs (8.02 ±1.37% vs.
1.11± 0.47%; Figure 3B) exhibited elevated early apoptosis
in the glucose-deprived condition compared to the ische-
mic condition.
Simulated 48 hr glucose deprivation and ischemia
in vitro resulted in late apoptosis/cell death defined by
impaired mitochondrial membrane potential and cellular
activity (Figure 3A & C). WT-MSC exposure to reduced
glucose for 48 hr showed an increase in late apoptosis
(7.47± 1.28% vs. 1.04± 0.69%; Figure 3C). Glucose
deprivation did not evoke alterations in the percentage of
MRL-MSC undergoing late apoptosis (2.08 ± 0.18% vs.
0.38± 0.21%; Figure 3C). The combination of decreased
oxygen and substrate availability showed an increase in
WT-MSCs (9.01 ± 2.19% vs. 1.04± 0.69%; Figure 3C) and
MRL-MSCs (2.33 ± 0.87% vs. 0.38± 0.21%; Figure 3C) late
apoptosis/cell death compared to control conditions
(Figure 3B). However, the proportion of non-viable MRL-
MSCs was significantly lower than that of WT-MSCs fol-
lowing 48 hr ischemia (2.33± 0.87% vs. 9.01± 2.19%;
Figure 3B). In summary, the aforementioned experiments
evaluated WT-and MRL-MSCs early and late apoptosis
following 48 hr of depressed substrate availability or ische-
mia in vitro. Our results suggest MRL-MSC exhibited a
lower rate of apoptosis compared to WT-MSCs under nu-
trient deprivation. Such characteristics may be transferable
to the in vivo conditions of the infarcted heart allowing
for greater MRL-MSC survival and a subsequent increase
in their therapeutic effects.
Discussion
Upon transplantation, MRL-MSCs exhibit increased en-
graftment and survival in the infarcted heart comparedto WT-MSCs [5]. We aimed to evaluate innate differ-
ences in mitochondrial function between these cell types
to explain differences in cell viability. Novel findings
identify unique energetic characteristics of MRL-MSCs
that would be protective in glucose-compromised and
ischemic environments.
Assessment of oxygen utilization in the intact cell
allowed for the determination of physiological respira-
tory states. MRL-MSCs displayed similar LEAK respir-
ation, however, routine respiration and maximal electron
transport capacity were greater. In order to eliminate the
potential confounding influence of mitochondrial dens-
ity, flux control ratios (FCR) were evaluated. Results
revealed a lower LEAK and routine respiration as a pro-
portion of maximal electron transport capacity in MRL-
MSCs. This suggests the presence of higher electron
transport capacity in MRL-MSCs. To identify regulatory
factors responsible for the increased OXPHOS potential,
two major sites of electron input into the electron trans-
port system (complex I and complex II) were examined.
In the presence of ADP, oxygen flux through complex I
was higher in the MRL-MSCs. Because complex I is not
the only site of electron input into the electron transport
system, succinate-supported, maximal respiration was
determined. This complex II-mediated oxygen flux was
higher in the MRL-MSCs and indicates a greater aerobic
energy production in the MRL-MSCs. Given the MSCs
are transplanted into the heart, we also assessed the oxy-
gen consumption of primary cardiac myocytes to pro-
vide a metabolic reference state to which MSC oxygen
utilization could be compared. Relative to the WT-
MSCs, cardiac myocyte VCI, VMAX-CI and VMAX-CII were
127-, 77- and 180-fold greater, respectively. This indi-
cates the oxidative capacity of MSCs is relatively minor
in comparison to that of cardiac myocytes and the MRL-
MSC respiration is only modestly higher than WT-
MSCs. The mechanism responsible for the increased in-
tact cell oxidative function and permeabilized cell com-
plex I and II activity in the MRL-MSCs is currently
unknown. Given the role of sFRP2 in modulating apop-
tosis and glucose metabolism, future experiments evalu-
ating the effect of sFRP2 on mitochondrial OXPHOS in
the WT-and MRL-MSCs are notable future endeavours.
Several reports conclude WT-MSCs preferentially de-
rive energy from glycolysis with little dependence on
glucose oxidation [20-22]. We report MRL-MSCs exhibit
elevated absolute OXPHOS function (RDMEM/MiR05,
VMAX-CI, VMAX-CII and ETS) and higher OXPHOS po-
tential (RDMEM/ETS). Based on these observations we
propose the slight elevation in OXPHOS displayed by
the ‘Superhealer’ MRL-MSCs is advantageous. For in-
stance, in MSCs, there is a shift towards OXPHOS de-
pendence under glucose deprivation [23]. The increase
in oxidative function is thought to be an adaptive
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shortage given OXPHOS produces approximately 32
moles of ATP per mole of glucose [24]. This is much
greater than the 2 moles of ATP resulting from glycoly-
sis [24]. To evaluate this hypothesis we cultured WT-
and MRL-MSCs under glucose-deprived conditions for
48 hr where oxygen was not limiting. We found that
WT-and MRL-MSCs displayed a reduction in mitochon-
drial membrane potential; an early indicator of apoptosis
[25]. However, WT-MSCs exhibited a significantly
higher proportion of cells with mitochondrial dysfunc-
tion compared to MRL-MSCs. Additionally, the percent-
age of late apoptotic cells was also higher in WT-MSCs
compared to the MRL-MSCs following the reduced sub-
strate conditions. The elevated routine oxygen flux and
electron transport capacity in MRL-MSCs may provide
benefits when faced with a lack of substrate by better ac-
commodating the switch towards oxidative metabolism.
This could assist in preservation of ATP levels and pre-
vent energetic starvation. Furthermore, a potential for
increased coupling of glycolysis to glucose oxidation in
MRL-MSCs could minimize intracellular acid load and
improve cell viability in the infarcted heart.
Recently, reports indicate that substrate deprivation is
much more detrimental to MSC survival than hypoxia
[20,22]. To expand on our glucose deprivation studies
we assessed MSC apoptosis following 48 hr of ischemia
(glucose and oxygen deprivation). Under the ischemia
conditions WT- and MRL-MSCs showed an elevated
proportion of late apoptotic/dead cells. However, there
was no added effect of depressed oxygen availability on
late apoptosis/cell death over reduced glucose availabil-
ity. These findings are consistent with the reports that
substrate availability and not hypoxia is more influential
in MSC viability. Also, the percentage of late apoptotic
cells was elevated in the WT-MSCs compared to the
MRL-MSCs which are in agreement with studies indicat-
ing MRL-MSC exhibit increased engraftment and sur-
vival in the infarcted heart [5].
Interestingly, ischemia had an unexpected influence on
impaired mitochondrial membrane potential/early apop-
tosis. The number of early apoptotic WT-and MRL-
MSCs was significantly lower following 48 hr of com-
bined substrate and oxygen reduction compared to early
apoptotic cells under decreased glucose conditions only.
The mechanism for this finding is currently unknown. It
is possible that the oxygen deprivation results in a com-
pensatory reduction in MSC oxidative metabolism
thereby exhibiting a protective effect on the MSCs by
finding a unique compromise between OXPHOS and
glycolysis. This speculative compromise may provide a
more optimal balance between ATP synthesis, glycolysis-
mediated acidosis from the lack of oxygen and reactive
oxygen species-induced damage resulting from OXPHOSunder non-limiting oxygen concentrations. Alternatively,
it cannot be ignored that ischemia may primarily induce
late apoptotic events independent of early mitochondrial
dysfunction. Of note, a limitation of this study is the use
of mineral oil to induce hypoxia without measuring oxy-
gen concentration in the culture medium. Future studies
should accurately measure oxygen concentrations to iden-
tify the effect of various oxygen levels in combination with
substrate deprivation on mitochondrial-induced apoptosis.
In conclusion, little attention has been given to the opti-
mal metabolic characteristics that would allow trans-
planted cells to cope with oxygen and glucose deprivation.
We found MRL-MSCs display elevated OXPHOS that
may minimize metabolic stress and subsequently improve
cell viability upon transplantation into the infarcted heart.
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